To investigate whether probiotic MR-61 can assist in slowing down the progression rate of myopia (a prospective randomized controlled study).
Myopia is defined as spherical equivalent (SE) ≤ -0.5D.
Aged between 3 and 18 years, with no restriction on gender.
Cylinder power ≤ 1.50D; anisometropia of SE between both eyes ≤ 1.50D.
The subject has sufficient compliance with the study follow-up; the subject or their guardian has the intention to receive treatment and has signed the informed consent form.
Presence of other concomitant ocular diseases;
Abnormal findings on clinical slit-lamp examination;
Existence of amblyopia, manifest strabismus, esotropia, or other congenital ocular diseases;
Individuals with abnormal intraocular pressure or abnormal axial length of the eye;